Navigation Links
Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
Date:8/11/2011

dvancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

About NUEDEXTA

NUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. Studies to support the effectiveness of NUEDEXTA were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). NUEDEXTA has not been shown to be safe and effective in other types of emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias. The primary outcome measure, laughing and crying episodes, was significantly lower in the NUEDEXTA arm compared to placebo. The secondary outcome measure, the Center for Neurologic Studies Lability Scale (CNS-LS), demonstrated a significantly greater mean decrease in CNS-LS score from baseline for the NUEDEXTA arm compared to placebo.

NUEDEXTA Important Safety Information

NUEDEXTA can interact with other medications causing significant changes in blood levels of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients rec
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015  Teradata (NYSE: TDC ... marketing applications company, today announced the ... Analytics Framework for Life Sciences helps organizations integrate ... and Early Discovery (RED), clinical analysis, Real-World Evidence ... relevant sources, companies can benefit by bringing safer, ...
(Date:4/20/2015)... --  Gateway Rehab and the Kenneth S. ... its Naloxone: Increasing Access, Saving Lives research project ... the Staunton Farm Foundation made expansion ... The yearlong research project, which provides overdose prevention ... upon completion of treatment and enrollment in the ...
(Date:4/20/2015)... , April 20, 2015 Pharmaceutical Research ... estimated $51.2 billion last year in the research and ... figure represents the majority of all biopharmaceutical R&D spending ... the United States . The new R&D numbers, ... companies, are highlighted in the newly released ...
Breaking Medicine Technology:Teradata Delivers Big Analytics Innovation for Life Sciences 2Teradata Delivers Big Analytics Innovation for Life Sciences 3Teradata Delivers Big Analytics Innovation for Life Sciences 4Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3
... CLARA, Calif. and TEL AVIV, Israel, May 22, ... focused on delivering mixed-signal semiconductors, modules and subsystems ... that it has signed a distribution agreement with ... and distributor, will be a key partner driving ...
... 2012  Today ZocDoc introduces its service ... access to appointments with Greater Denver,s leading doctors, ... launch, this free service provides patients with their ... primary care doctors, obstetrician-gynecologists, dermatologists and eye doctors ...
Cached Medicine Technology:Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 3Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 4
(Date:4/20/2015)... Early registration is open for the 2nd ... at the start line. Returning to James Kealoha Beach ... to 500 participants (actually there’s only 499 spots since Big ... Now thru April 30, the entry fee is only $150 ... 1st, the fee goes up to $200 and $100, respectively. ...
(Date:4/20/2015)... 2015 TROY Healthcare Solutions will be ... (TSPE) software, which provides the ultimate level of security ... at the Anthem Suite Hotel in the Socrates Room, ... AM. , Beginning at 7 AM, TROY Healthcare Solutions ... TROY Healthcare Solutions will offer brief 15-20 minute presentations ...
(Date:4/20/2015)... Billings, Montana (PRWEB) April 20, 2015 ... foundation has done for our family. Initially, I really ... that's where it would end. But what I've discovered ... including myself, to be together, support each other and ... Founder Kori Keller. "I have learned way more from ...
(Date:4/20/2015)... Tympani Inc., an IT consulting and ... services business 175% this year. Tympani offers a ... to its traditional IT infrastructure, communications and managed ... cloud partners Faction and Seagate Technology, will present ... a Cloud Symposium on April 23 in Rosemont, ...
(Date:4/20/2015)... April 20, 2015 The 2015 ... Industry is a professional and in-depth study on ... Besylate Market with a focus on the ... the amlodipine besylate market research are Pfizer, Novartis, ... Reddy's Lab., Par Pharma, Cadila Pharmaceuticals, Kangya Pharmaceuticals, ...
Breaking Medicine News(10 mins):Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 2Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 3Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3
... ... their 1st annual Toy Drive benefiting Providence Hospital’s “Adopt-a-Family for Christmas” program. The goal ... that goal is achieved, Bobby Berk Home will match the donation. Toys will be ... ...
... , LOS ANGELES, Dec. 4 Yogen Fruz ... of its holiday themed "NUmixes" -- Yog-Nog and ... will be unveiled at Yogen Fruz stores across North America. Yogen ... a guilt-free dessert alternative to indulge in this holiday season. ...
... ... host continuing medical education courses at their medical facility in 2010. This program allows a ... their overall costs to educate their physical therapy and occupational therapy team members. In 2009 ... ...
... , OAKLAND, Calif., Dec. 4 Herpes zoster, ... have been vaccinated against chicken pox, according to a Kaiser ... Infectious Diseases Journal. , The study, the largest of ... 170,000 children vaccinated with the varicella (chicken pox) vaccine from ...
... Dec. 3 The Cancer Center at Harrington ... announced today. , "We expect to start seeing patients immediately," ... , The approval was granted today by the Massachusetts Department ... the facility. , The opening of The Cancer Center ...
... , CHICAGO, Dec. 3 The ... States District Court for the Southern District of New ... $350 million settlement that would resolve a class-action lawsuit ... AMA, Medical Society of the State of New York ...
Cached Medicine News:Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Yogen Fruz Introduces New Holiday Flavors: Yog-Nog and Mint Chocolate Chip 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2
... Screw and Washer is a ... soft tissue re-attachments in the ... and washer provides the fixation ... screw and washer but has ...
... The Biosteon™ screw is made of ... Acid (PLLA). It not only has the ... it has the osteoconductive potential of bone. ... BTB and Soft Tissue procedures. Biosteon™ increases ...
... Threaded Dilator System offers ... choice for drilling their ... compaction reaming versus conventional ... bone within the tunnel ...
... Medicine Knot Pusher is a reusable instrument used ... Knot Pusher is utilized in the handling and ... two piece shaft allows the surgeon to place ... pushing. The ring handle allows the surgeon ease ...
Medicine Products: